Posted by: admin on: September 22, 2011
The US Food and Drug Administration (FDA) has approved icatibant subcutaneous injection (Firazyr) for the treatment of acute attacks of hereditary angioedema (HAE) in adults aged 18 years and older. -Team@CMHF
Posted by: admin on: September 21, 2011
The US Food and Drug Administration (FDA) announced approval for the use of onabotulinumtoxinA (Botox) to treat urinary incontinence resulting from detrusor over activity in patients with spinal cord injury and multiple sclerosis (MS) -Team@CMHF
Posted by: admin on: September 21, 2011
Although the updated heart failure guidelines from the U.K.’s National Institute for Health and Clinical Excellence (NICE) are broadly consistent with similar guidelines from Europe and the U.S., outside experts are questioning several key details of the update. -Team@CMHF
Posted by: admin on: September 21, 2011
Less than two years after a key supervision charge force endorsed that many women in their 40s might not need mammograms, the nation’s largest organisation representing obstetricians and gynecologists has suggested women in that age organisation to have annual mammograms. -Team@CMHF
Posted by: admin on: September 20, 2011
Although individuals with obesity and Type 2 diabetes are insulin resistant, pancreatic β-cell failure is the core defect that distinguishes individuals who eventually develop diabetes. This process is known to occur well before the onset of hyperglycemia. Although clinical trial data support the effectiveness of intensive lifestyle modification in delaying the onset of diabetes in […]